Compare $DCOY vs $ORGS | Chartloom

Compare

$DCOY vs $ORGS

Decoy Therapeutics Inc · Orgenesis Inc

DCOY

Decoy Therapeutics Inc

ORGS

Orgenesis Inc

Compare $DCOY vs $ORGS

Comparing Decoy Therapeutics Inc and Orgenesis Inc

DCOYDecoy Therapeutics Inc

ORGSOrgenesis Inc

DCOYDecoy Therapeutics Inc

Market cap

$779K

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-97.0%

FCF yield

-1073.9%

ORGSOrgenesis Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-92.8%

YTD performance

133.3%

52W performance

-56.3%

FCF yield

-505.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DCOY

ORGS

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

ORGS

Orgenesis Inc

Market Cap

DCOY$779K

ORGS$3M

Enterprise Value

DCOY$-8M

ORGS$20M

Price

DCOY$1.47

ORGS$0.35

P/E Ratio

DCOYN/A

ORGSN/A

P/S Ratio

DCOY3.42x

ORGS3.31x

EV/Sales

DCOY-33.00x

ORGS19.39x

EV/EBITDA

DCOY0.00x

ORGS0.00x

P/B Ratio

DCOY0.75x

ORGS0.28x

P/FCF Ratio

DCOYN/A

ORGSN/A

EV/FCF

DCOY0.90x

ORGS-1.16x

PEG Ratio

DCOYN/A

ORGSN/A

Forward P/E (NTM)

DCOYN/A

ORGSN/A

Forward P/S (NTM)

DCOYN/A

ORGSN/A

Revenue (TTM)

DCOY$228K

ORGS$1M

Revenue Growth (YoY)

DCOYN/A

ORGS-92.8%

Forward Rev Growth

DCOY0.0%

ORGS0.0%

Gross Margin (TTM)

DCOY48.6%

ORGS-86.3%

Operating Margin (TTM)

DCOY0.0%

ORGS0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

ORGS-1868.2%

Net Margin (TTM)

DCOY-6348.7%

ORGS-4653.6%

FCF Margin (TTM)

DCOY-3676.1%

ORGS-1675.3%

Net Income (TTM)

DCOY$-14M

ORGS$-48M

FCF (TTM)

DCOY$-8M

ORGS$-17M

EPS (TTM)

DCOY-$27.16

ORGS-$9.58

ROE (TTM)

DCOY-31523.0%

ORGS-10936.0%

ROA (TTM)

DCOY-16715.0%

ORGS-20820.0%

ROIC (TTM)

DCOY-31523.0%

ORGS-5864.0%

Cash

DCOY$8M

ORGS$78K

Debt

DCOY$0

ORGS$17M

Net Cash/Debt

DCOY$8M

ORGS$-17M

Current Ratio (TTM)

DCOY1.83x

ORGS0.03x

Quick Ratio (TTM)

DCOY1.77x

ORGS0.03x

Debt/Equity (TTM)

DCOY0.00x

ORGS1.73x

Debt/Assets (TTM)

DCOY0.0%

ORGS0.0%

Interest Coverage (TTM)

DCOYN/A

ORGSN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

ORGS0.00x

Beta

DCOY0.68

ORGS3.73

52W Performance

DCOY-97.0%

ORGS-56.3%

YTD Performance

DCOY-81.2%

ORGS133.3%

% from 52W High

DCOY-97.4%

ORGS-65.0%

% from 52W Low

DCOY0.7%

ORGS34900.0%

Asset Turnover (TTM)

DCOY0.03x

ORGS0.04x

FCF Yield (TTM)

DCOY-1073.9%

ORGS-505.5%

Earnings Yield (TTM)

DCOY-1854.7%

ORGS-1404.2%

Dividend Yield (TTM)

DCOYN/A

ORGSN/A

Rule of 40

DCOY-3,676.1

ORGS-1,768.0

EV/GP/RG

DCOYN/A

ORGSN/A

Ticker research

View DCOY research View ORGS research

Metric	DCOY Decoy Therapeutics Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$20M
Price	$1.47	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	3.31x
EV/Sales	-33.00x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$1M
Revenue Growth (YoY)	N/A	-92.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	-86.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	-1868.2%
Net Margin (TTM)	-6348.7%	-4653.6%
FCF Margin (TTM)	-3676.1%	-1675.3%
Net Income (TTM)	$-14M	$-48M
FCF (TTM)	$-8M	$-17M
EPS (TTM)	-$27.16	-$9.58
ROE (TTM)	-31523.0%	-10936.0%
ROA (TTM)	-16715.0%	-20820.0%
ROIC (TTM)	-31523.0%	-5864.0%
Financial Health
Cash	$8M	$78K
Debt	$0	$17M
Net Cash/Debt	$8M	$-17M
Current Ratio (TTM)	1.83x	0.03x
Quick Ratio (TTM)	1.77x	0.03x
Debt/Equity (TTM)	0.00x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	3.73
52W Performance	-97.0%	-56.3%
YTD Performance	-81.2%	133.3%
% from 52W High	-97.4%	-65.0%
% from 52W Low	0.7%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.04x
FCF Yield (TTM)	-1073.9%	-505.5%
Earnings Yield (TTM)	-1854.7%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	-1,768.0
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View ORGS research

Valuation

P/S Ratio

ORGS

3.31x

DCOY

3.42x

EV/FCF

ORGS

-1.16x

DCOY

0.90x

Growth & revenue

Revenue Growth TTM

ORGS

-92.8%

Forward Revenue Growth

DCOY

0.0%

ORGS

0.0%

Profitability & performance

Gross Margin

DCOY

48.6%

ORGS

-86.3%

ROE

ORGS

-10936.0%

DCOY

-31523.0%

FCF Yield %

ORGS

-505.5%

DCOY

-1073.9%

52-Week Performance

ORGS

-56.3%

DCOY

-97.0%

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

ORGS

Orgenesis Inc

Market Cap

DCOY$779K

ORGS$3M

Enterprise Value

DCOY$-8M

ORGS$20M

Price

DCOY$1.47

ORGS$0.35

P/E Ratio

DCOYN/A

ORGSN/A

P/S Ratio

DCOY3.42x

ORGS3.31x

EV/Sales

DCOY-33.00x

ORGS19.39x

EV/EBITDA

DCOY0.00x

ORGS0.00x

P/B Ratio

DCOY0.75x

ORGS0.28x

P/FCF Ratio

DCOYN/A

ORGSN/A

EV/FCF

DCOY0.90x

ORGS-1.16x

PEG Ratio

DCOYN/A

ORGSN/A

Forward P/E (NTM)

DCOYN/A

ORGSN/A

Forward P/S (NTM)

DCOYN/A

ORGSN/A

Revenue (TTM)

DCOY$228K

ORGS$1M

Revenue Growth (YoY)

DCOYN/A

ORGS-92.8%

Forward Rev Growth

DCOY0.0%

ORGS0.0%

Gross Margin (TTM)

DCOY48.6%

ORGS-86.3%

Operating Margin (TTM)

DCOY0.0%

ORGS0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

ORGS-1868.2%

Net Margin (TTM)

DCOY-6348.7%

ORGS-4653.6%

FCF Margin (TTM)

DCOY-3676.1%

ORGS-1675.3%

Net Income (TTM)

DCOY$-14M

ORGS$-48M

FCF (TTM)

DCOY$-8M

ORGS$-17M

EPS (TTM)

DCOY-$27.16

ORGS-$9.58

ROE (TTM)

DCOY-31523.0%

ORGS-10936.0%

ROA (TTM)

DCOY-16715.0%

ORGS-20820.0%

ROIC (TTM)

DCOY-31523.0%

ORGS-5864.0%

Cash

DCOY$8M

ORGS$78K

Debt

DCOY$0

ORGS$17M

Net Cash/Debt

DCOY$8M

ORGS$-17M

Current Ratio (TTM)

DCOY1.83x

ORGS0.03x

Quick Ratio (TTM)

DCOY1.77x

ORGS0.03x

Debt/Equity (TTM)

DCOY0.00x

ORGS1.73x

Debt/Assets (TTM)

DCOY0.0%

ORGS0.0%

Interest Coverage (TTM)

DCOYN/A

ORGSN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

ORGS0.00x

Beta

DCOY0.68

ORGS3.73

52W Performance

DCOY-97.0%

ORGS-56.3%

YTD Performance

DCOY-81.2%

ORGS133.3%

% from 52W High

DCOY-97.4%

ORGS-65.0%

% from 52W Low

DCOY0.7%

ORGS34900.0%

Asset Turnover (TTM)

DCOY0.03x

ORGS0.04x

FCF Yield (TTM)

DCOY-1073.9%

ORGS-505.5%

Earnings Yield (TTM)

DCOY-1854.7%

ORGS-1404.2%

Dividend Yield (TTM)

DCOYN/A

ORGSN/A

Rule of 40

DCOY-3,676.1

ORGS-1,768.0

EV/GP/RG

DCOYN/A

ORGSN/A

Ticker research

View DCOY research View ORGS research

Metric	DCOY Decoy Therapeutics Inc	ORGS Orgenesis Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$20M
Price	$1.47	$0.35
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	3.31x
EV/Sales	-33.00x	19.39x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	0.28x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	-1.16x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$1M
Revenue Growth (YoY)	N/A	-92.8%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	-86.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	-1868.2%
Net Margin (TTM)	-6348.7%	-4653.6%
FCF Margin (TTM)	-3676.1%	-1675.3%
Net Income (TTM)	$-14M	$-48M
FCF (TTM)	$-8M	$-17M
EPS (TTM)	-$27.16	-$9.58
ROE (TTM)	-31523.0%	-10936.0%
ROA (TTM)	-16715.0%	-20820.0%
ROIC (TTM)	-31523.0%	-5864.0%
Financial Health
Cash	$8M	$78K
Debt	$0	$17M
Net Cash/Debt	$8M	$-17M
Current Ratio (TTM)	1.83x	0.03x
Quick Ratio (TTM)	1.77x	0.03x
Debt/Equity (TTM)	0.00x	1.73x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	3.73
52W Performance	-97.0%	-56.3%
YTD Performance	-81.2%	133.3%
% from 52W High	-97.4%	-65.0%
% from 52W Low	0.7%	34900.0%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.04x
FCF Yield (TTM)	-1073.9%	-505.5%
Earnings Yield (TTM)	-1854.7%	-1404.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	-1,768.0
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View ORGS research